Fundraising Foxソレイジア・ファーマ株式会社
2 known investors
Find your way into ソレイジア・ファーマ株式会社
Sign up to see every warm intro you have to ソレイジア・ファーマ株式会社
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ソレイジア・ファーマ株式会社 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Solasia is a pharmaceutical company that in-licenses promising drug candidates from overseas and domestic pharma and biotech companies and develops them through clinical trials for the Japanese and Asian markets. Founded in 2006, it focuses on supplying cancer-related medicines to patients across Japan and other Asian countries.
Investors · 2
Nippon Venture Capitallisted by Nippon Venture CapitalTokyo · $300K – $5M
How we know: Nippon Venture Capital's portfolio page · Not right? Tell us
SMBC Venture Capitallisted by SMBC Venture CapitalTokyovia Hiroya Ota · inferred
How we know: SMBC Venture Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does ソレイジア・ファーマ株式会社 do?
- Solasia is a pharmaceutical company that in-licenses promising drug candidates from overseas and domestic pharma and biotech companies and develops them through clinical trials for the Japanese and Asian markets. Founded in 2006, it focuses on supplying cancer-related medicines to patients across Japan and other Asian countries.
- Who are ソレイジア・ファーマ株式会社's investors?
- ソレイジア・ファーマ株式会社's investors include Nippon Venture Capital, SMBC Venture Capital.